Digital Showroom

An online marketplace where you can search quality exhibitors
and products covering the entire pharma supply chain

  • Aasenbo Pharma Co.,Ltd,Beijing

    Booth: Country/Region: China Mainland

      We act as sale agent in china for foreign companies, we also provide regulatory service foreign companies. We are strong in import drug registration and promotion import API, with more than 14 years experience and more than 80 Licenses procured successfully.  Our knowledge, experience and good working relationship with the regulatory department help us to speed up regulatory approvals and provide sound support our formulation customers.
  • Anhui Changjiang Pharmaceutical Co.,Ltd

    Booth: Country/Region: China Mainland

  • Anhui Pioneer Pharmaceutical Co.,Ltd.

    Booth: Country/Region: China Mainland

    Anhui Pioneer Pharmaceutical Co., Ltd, founded in Jan 2004, is a pharmaceutical enterprise engages in pharmaceutical research and development, drug manufacturing, and international trade. It locates in Hefei of China, covering an area about 20000m2. Pioneer has several advanced production lines for injections, capsules, tablets, granules with Chinese GMP certificates, with total workshop area about 30000 m2. The company has about 300 staff, among which about 40 were research staff. Two research centers have been founded, one located in Hefei, and the other located in Shanghai,and a set of technological innovation system has also been established. Our company was identified by the Department of Science and Technology of Anhui Province as a "High-Tech Enterprise" in 2012. Pioneer makes good collaboration with domestic API factories and develops drug formulations, now the company hold 72 drug formulations with approval number from CFDA. The products cover antibiotics, cardio-cerebrovascular, respiratory, digestive and other fields. In 2017, our revenue had reached about 200 million Yuan. Pioneer obtained certificates in quality, environment, occupational health and safety management: ISO9001-2015、ISO14001-2015 、GB/T28001-2011/OHSAS18001:2007. We look forward to establish long-term business relations with your company and promote mutual development.
  • Asia Talent Chemical Limited.

    Booth: Country/Region: China Mainland

    ASIA TALENT CHEMICAL LTD   established in 1999 in Hongkong and ever since has been growing rapidly, ATC is now one of the leading suppliers and sharer in Great China and Southern Eastern Asia serving the needs of esteemed distributors and end users globally. Efficient and cost-effective Supply Chain Management, Custom Synthesis and Toll Manufacturing are the major business models we pursue. ATC is committed to the success of its partners through creating added value within our global supply chain. We serve as outsourcing partner for our customers in a selected range of chemicals. Over fifty dedicated and experienced specialists here are ready to provide professional service to our customers all the time. We are open, flexible, fast and reliable. We pride ourselves in being strategic partner of a number of prestigious companies worldwide. Bolstered by our intensive market knowledge and solid relations with reliable manufacturers, we invite more companies to have in-depth cooperation
  • Beijing Beilu Pharmaceutical Co., Ltd

    Booth: Country/Region: China Mainland

    Beijing BeiLu Pharmaceutical Co.,Ltd. was established in September 1992, mainly engaged in pharmaceutical product development, production and sales. As a high-tech pharmaceutical enterprise jointly identified by the Ministry of Science and Technology, Ministry of Finance and State Administration of Taxation, Beijing BeiLu Pharmaceutical Co.,Ltd. has been committed to the development of universal health, adhering to scientific and technological innovation, creating wealth for the country, contributing to the society, and promoting the growth of enterprise. The company adheres to the business philosophy of "market segment, largest share", clarifying the business development direction in the future. At present, the main products of the company constitute the contrast agent, mental & nerve series and hypoglycemic products. As the first enterprise developed and launched the contrast agents, Beijing BeiLu Pharmaceutical Co.,Ltd. has provided high-quality, safe, reasonably priced products by virtue of technical innovation, process improvement and other measures, giving a significant impetus to the clinical application and development of contrast agent products in China. The company’s products has formed a unique core competitive advantage in this area, enjoying a high visibility and market impact, covering various hospitals above the province, municipality, and county level in China. Beijing BeiLu Pharmaceutical Co.,Ltd. emphasizes on the quality training of marketing staff and the improvement of professional level, gradually establishing a stable, experienced marketing team, in order to better serve doctors and patients.          The Company adheres to the philosophy of people-oriented, strengthening respect, understanding, concern, and care of staff in the management. Cultivating the staff’s corporate responsibility, social responsibility and family responsibility, encouraging the staff to innovate, and hence the Company has formed a stable, harmonious internal environment. In the meanwhile, Beijing BeiLu Pharmaceutical Co.,Ltd. strives to create a unique corporate culture in terms of core values, code of conduct and so forth.         The Company advocates innovation, rigorous style of work, which has made remarkable achievements over the last decade, awarded as A-level Corporate Tax Credit, Zhongguancun Top100 Innovative Pilot Enterprises for many years; won the national invention patents, state-level new product certificate, Beijing Science and Technology Progress Award and other awards; its main products also were included in the national Torch Program, the Beijing Torch Program, Beijing major industrial projects, accessing to all levels of financial support; in 2010, the Company was formally listed in the first-batch scale enterprises of Beijing Biomedical Industry Forward Development Project (G20 Project); in 2010, the Company was named as the " Top 50 Core Competitiveness of Pharmaceutical Listed Enterprises" by the Chinese Academy of Social Sciences, China Medical Information Professional Committee and the industry's leading experts.         On October 30, 2009, the Company publicly listed on the Shenzhen Stock Exchange GEM as one of the first batch of 28 enterprises, indicating that the Company has embarked upon a new historical course and the future holds even brighter prospects. In the future, the Company shall, in virtue of technical innovation, management innovation, professional academic promotion and fund-raising projects, enhance the new drug research and development capabilities, production capacity, operational efficiency, market share and profitability, as well as consolidate and improve the company's core competitiveness.  
  • CF PharmTech,Inc.

    Booth: Country/Region: China Mainland

    CF PharmTech was founded in 2007, it is a fully independent, dynamic, integrated, specialty pharmaceutical company focused on the development and manufacturing of products for the treatments of asthma, COPD and allergic rhinitis for the global market. Its mission is to develop high-quality and affordable medicine to help patients achieve effective management care for their respiratory diseases. The headquarters is located in the lakeside of the Caohu District of Suzhou, Jiangsu Province, with many very convenient transportation options available. It only takes thirty minutes by train to Shanghai and four hours by train to Beijing.
  • Chengdu Baiyu Pharmaceutical Co., Ltd.

    Booth: Country/Region: China Mainland

    A leading pharmaceutical company engaged in R&D, manufacturing and marketing of high quality medicinal products with special focus on CVS/CNS areas. Our manufacturing sites comply with EU/FDA/China GMP. Ginkgolide injection is a global innovative herbal medicinal product of its kind for treatment of mild-moderate cerebral infarction. Other  generic products  are Enoxaparin sodium injection, pantoprazole sodium for injection, etc.  Over 20 generic drugs are under development. We also provide contract manufacture service of liquid injectables, lyophilized, tablets and capsules and cooperate with firms to introduce high-end pharmaceutical products into Chinese market.Baiyu are open to any business cooperation that can bring benefits to both sides. In 2020, Baiyu Medical Supplies is founded and provide high quality of Personal Protective Equipment to again COVID-19, and relevant products(KN95, Disposable Medical mask, FFP3, FFP2, Type IIR) have launched around the whole world.
  • Chengdu Easton Biopharmaceuticals Co., Ltd.

    Booth: Country/Region: China Mainland

    Established in 2009 and headquartered in Chengdu High-tech district, Chengdu Easton Biopharmaceuticals Co., Ltd. is a Hi-tech pharmaceutical company, engaging in development, manufacture and distribution of commercial-scale Finished Dosage Forms (FDFs) and Active Pharmaceutical Ingredients (APIs). Our manufacturing facilities are fully compliant with EU-GMP and US-GMP standards. Easton Biopharma has two manufacture sites and two sales companies. Formulation manufacturing site, located in Chengdu headquarter, has four Chinese cGMP-compliant production lines including Tablets, Capsules, Injection solutions and Lyophilization vials. API manufacturing site, located in Meishan, Sichuan Province, has ten CFDA approved APIs. Easton Biopharma implements innovation-driven strategy for achieving sustainable development, with focusing on continuant improvement of R&D system. We are equipped with a scientific R&D platform including QC labs, R&D center and post-doctoral center. We aim to develop and produce new and generic drugs in the fields of Diabetics, Cardiovascular, Oncology, Anesthetic, Analgesics and Biopharmaceuticals.  
  • CISEN PHARMACEUTICAL CO.,LTD

    Booth: Country/Region: China Mainland

    Cisen Pharmaceutical Co., Ltd., an integrated chemical production enterprise, developed from Jining third pharmaceutical factory founded in 1970, restructured to form Shandong Lukang Cisen Pharmaceutical Co., Ltd. in 1998, officially changed its name in July 1st,2011. Cisen has developed into a modern pharmaceutical company, with 4 subsidiaries (branches) throughout China, all this rapid development took place within recent 16 years. According to the 2013 sales ranking of chemical industry enterprises 100, Cisen ranked Top 44. Production and sales of the infusion solution ranked the third in China. Cisen Pharmaceutical is specialized in manufacture and sale of more than 400 different products, including IV solutions, lyophilized, sterile powders for injections, small volume parenteral, tablets, capsules, ointment, eye(ear) drops, API and so on. In the future, Cisen will continue to increase R&D efforts in sterile preparation, to secure its technology and product advantage; secondly, the cGMP workshop will ensure new products smoothly production and be approved by U.S. FDA in 2015; thirdly, we will emphasize the R&D of antineoplastic, narcotic, nutriceutical, endocrine system, cardiovascular and cerebrovascular drugs, improving the management level of the preparation quality, realizing its internationalization. Cisen Pharmaceutical will strive to be one of the largest pharmaceutical manufacturers in China, featuring the largest scale, the widest range of product specification, the highest profit margin as well as the strongest competitiveness.  
  • Fujian Yewpark Biological Co., Ltd

    Booth: Country/Region: China Mainland

       Fujian Yewpark is a high-tech enterprise that integrates research and development, production and sales of taxane APIs and intermediates, as well as the plantation of Taxus Chinensis. It was built in 2008 and the total investment of RMB148 million was poured into the company.     After years of efforts, we have built numbers of complete and advanced production lines, including extraction、 separation、 purification and semi-synthesis, equipped with full set of analytical instruments and equipment. The company has a strong production capacity and R&D technology of taxane products. The annually production capacity of natural Paclitaxel, 10-Deacetylbaccatin Ⅲ and its by-products are 2500 kilograms.      At present, it has received 2 national registered trademarks, 2 national invention patents and 8 utility model patents. The company has passed ISO9001 Quality Management System Certification, ISO14001 Environmental Management System Certification and Clean Production Certification. .
First pagePrevious pageNext pageLast page
Copyright 2006-2020 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by